Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from German Breast Centers.
Schäffler H, Jakob D, Huesmann S, Pfister K, Veselinovic K, Schochter F, Leinert E, Fink V, Rack B, Englisch A, Volmer LL, Engler T, Frevert ML, Juhasz-Böss I, Brucker S, Heublein S, Janni W, Taran FA, Hartkopf A, Dannehl D. Schäffler H, et al. Among authors: englisch a. Geburtshilfe Frauenheilkd. 2024 Sep 2;84(9):855-865. doi: 10.1055/a-2375-5194. eCollection 2024 Sep. Geburtshilfe Frauenheilkd. 2024. PMID: 39229630 Free PMC article.
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers.
Schäffler H, Mergel F, Pfister K, Lukac S, Fink A, Veselinovic K, Rack B, Fink V, Leinert E, Dimpfl M, Englisch A, Tegeler CM, Seller A, Grischke EM, Hahn M, Volmer LL, Engler T, Frevert ML, Taran FA, Janni W, Brucker SY, Hartkopf AD, Dannehl D. Schäffler H, et al. Among authors: englisch a. Int J Mol Sci. 2023 Nov 15;24(22):16366. doi: 10.3390/ijms242216366. Int J Mol Sci. 2023. PMID: 38003555 Free PMC article.
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysis.
Dannehl D, Jakob D, Mergel F, Estler A, Engler T, Volmer L, Frevert ML, Matovina S, Englisch A, Tegeler CM, Rohner A, Seller A, Hahn M, Pfister K, Fink A, Popp I, Lorenz S, Tabatabai G, Juhasz-Böss I, Janni W, Brucker S, Taran FA, Hartkopf A, Schäffler H. Dannehl D, et al. Among authors: englisch a. ESMO Open. 2024 May;9(5):102995. doi: 10.1016/j.esmoop.2024.102995. Epub 2024 Apr 17. ESMO Open. 2024. PMID: 38636292 Free PMC article.
Impact of obesity on pathological complete remission in early stage breast cancer patients after neoadjuvant chemotherapy: a retrospective study from a German University breast center.
Englisch JF, Englisch A, Dannehl D, Eissler K, Tegeler CM, Matovina S, Volmer LL, Wallwiener D, Brucker SY, Hartkopf A, Engler T. Englisch JF, et al. Among authors: englisch a. Arch Gynecol Obstet. 2024 Oct 28. doi: 10.1007/s00404-024-07786-7. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 39466403
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens.
Englisch A, Hayn C, Jung S, Heitmann JS, Hackenbruch C, Maringer Y, Nelde A, Wacker M, Denk M, Zieschang L, Kammer C, Martus P, Salih HR, Walz JS. Englisch A, et al. Front Oncol. 2024 Aug 26;14:1441625. doi: 10.3389/fonc.2024.1441625. eCollection 2024. Front Oncol. 2024. PMID: 39252947 Free PMC article.
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients.
Jung S, Nelde A, Maringer Y, Denk M, Zieschang L, Kammer C, Özbek M, Martus P, Hackenbruch C, Englisch A, Heitmann JS, Salih HR, Walz JS. Jung S, et al. Among authors: englisch a. Front Oncol. 2024 Oct 14;14:1458449. doi: 10.3389/fonc.2024.1458449. eCollection 2024. Front Oncol. 2024. PMID: 39469638 Free PMC article.
VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma.
Englisch A, Altvater B, Kailayangiri S, Hartmann W, Rossig C. Englisch A, et al. Pediatr Blood Cancer. 2020 Oct;67(10):e28313. doi: 10.1002/pbc.28313. Epub 2020 Jul 30. Pediatr Blood Cancer. 2020. PMID: 32729251
13 results